Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

An Activist’s Guide to Treatment for Drug-Resistant Tuberculosis

Book
An Activist’s Guide to Treatment for Drug-Resistant Tuberculosis

This guide details 2020 updates to the WHO guidelines about the global standard of care for drug-resistant TB. The guide also includes messaging and strategies that can be used to advocate for WHO-recommended regimens.

Author:

Treatment Action Group (TAG)

Audiences:

International Agencies, Policy Makers

Topic:

Advocacy/Communications, Extensively Drug-Resistant TB (XDR TB), MDR TB, TB Treatment

Country of Origin:

United States

Download PDF

Related Materials

An Activist’s Guide to Tuberculosis Drugs

This guide provides a summary of safety and efficacy data for drugs currently in use to treat TB. The guide also suggests advocacy points for activists, clinicians, and others working in TB.

Teaching Guide

An Activist’s Guide to Rifapentine for the Treatment of TB Infection

This guide details safety, efficacy, and access information on rifapentine. The guide also provides activists with the evidence and content needed to advocate for rifapentine to be available, accessible, and affordable to those who may need it.

Book

An Activist’s Guide to Tuberculosis Diagnostic Tools

This guide provides an overview of TB diagnostic tools and suggests recommendations for how activists and clinicians can contribute to improved TB diagnosis.

Toolkit

Global resources for the prevention,
management, and elimination of TB.